BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bi Y, Kong P, Zhang L, Cui H, Xu X, Chang F, Yan T, Li J, Cheng C, Song B, Niu X, Liu X, Liu X, Xu E, Hu X, Qian Y, Wang F, Li H, Ma Y, Yang J, Liu Y, Zhai Y, Wang Y, Zhang Y, Liu H, Liu J, Wang J, Cui Y, Cheng X. EP300 as an oncogene correlates with poor prognosis in esophageal squamous carcinoma. J Cancer 2019;10:5413-26. [PMID: 31632486 DOI: 10.7150/jca.34261] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu WJ, Zhao Y, Chen X, Miao ML, Zhang RQ. Epigenetic modifications in esophageal cancer: An evolving biomarker. Front Genet 2022;13:1087479. [PMID: 36704345 DOI: 10.3389/fgene.2022.1087479] [Reference Citation Analysis]
2 Du QC, Wang XY, Hu CK, Zhou L, Fu Z, Liu S, Wang J, Ma YY, Liu MY, Yu H. Integrative analysis of platelet-related genes for the prognosis of esophageal cancer. World J Clin Cases 2022; 10(33): 12077-12088 [DOI: 10.12998/wjcc.v10.i33.12077] [Reference Citation Analysis]
3 Xiao S, Huang G, Zeng W, Zhou J, Li Y, Fan T, Liu X, Xia J, Zeng X. Roles of oncogenes in esophageal squamous cell carcinoma and their therapeutic potentials. Clin Transl Oncol 2022. [DOI: 10.1007/s12094-022-02981-x] [Reference Citation Analysis]
4 Bispo IMC, Granger HP, Almeida PP, Nishiyama PB, de Freitas LM. Systems biology and OMIC data integration to understand gastrointestinal cancers. World J Clin Oncol 2022; 13(10): 762-778 [DOI: 10.5306/wjco.v13.i10.762] [Reference Citation Analysis]
5 Situ Y, Lu X, Cui Y, Xu Q, Deng L, Lin H, Shao Z, Chen J, Aziz AUR. Systematic Analysis of CXC Chemokine–Vascular Endothelial Growth Factor A Network in Colonic Adenocarcinoma from the Perspective of Angiogenesis. BioMed Research International 2022;2022:1-19. [DOI: 10.1155/2022/5137301] [Reference Citation Analysis]
6 Chen Z, Chen C, Li L, Zhang T, Wang X. Pan-Cancer Analysis Reveals That E1A Binding Protein p300 Mutations Increase Genome Instability and Antitumor Immunity. Front Cell Dev Biol 2021;9:729927. [PMID: 34616736 DOI: 10.3389/fcell.2021.729927] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Konoshenko MY, Laktionov PP. MiRNAs and radical prostatectomy: Current data, bioinformatic analysis and utility as predictors of tumour relapse. Andrology 2021;9:1092-107. [PMID: 33638886 DOI: 10.1111/andr.12994] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhu D, Ren X, Luo Y, Huang B, Huang J. Bladder Malignant Granular Cell Tumor with EP300 Gene Mutation: A Case Report and Literature Review. JCT 2021;12:240-253. [DOI: 10.4236/jct.2021.125023] [Reference Citation Analysis]
9 Liang C, Niu J, Wang X, Zhang ZS, Yang RH, Yao X, Liu FY, Li WQ, Pei SH, Sun H, Wang CJ, Fang D, Xie SQ. P300-dependent acetylation of histone H3 is required for epidermal growth factor receptor-mediated high-mobility group protein A2 transcription in hepatocellular carcinoma. Cancer Sci 2021;112:679-90. [PMID: 33164305 DOI: 10.1111/cas.14729] [Cited by in Crossref: 6] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang D, Cui Y, Xu A, Zhao L, Li P. MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4. Cancer Cell Int 2020;20:447. [PMID: 32943995 DOI: 10.1186/s12935-020-01497-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
11 He W, Leng X, Yang Y, Peng L, Shao Y, Li X, Han Y. Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History. Onco Targets Ther 2020;13:8795-802. [PMID: 32943884 DOI: 10.2147/OTT.S262512] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
12 Sun C, Guo Y, Zhou W, Xia C, Xing X, Chen J, Li X, Zhu H, Lu J. p300 promotes cell proliferation through suppressing Kaposi's sarcoma-associated herpesvirus (KSHV) reactivation in the infected B-lymphoma cells. Virus Res 2020;286:198066. [PMID: 32553609 DOI: 10.1016/j.virusres.2020.198066] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]